The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amdocs Ltd
NASDAQ:DOX
|
GG |
|
N
|
Nebius Group NV
F:YDX
|
NL |
|
G
|
GoDaddy Inc
SWB:38D
|
US |
|
Concurrent Technologies PLC
LSE:CNC
|
UK |
|
M
|
Mitsubishi UFJ Financial Group Inc
F:MFZA
|
JP |
|
Corning Inc
NYSE:GLW
|
US |
|
Sartorius Stedim Biotech SA
F:56S0
|
FR |
|
S
|
Scodix Ltd
TASE:SCDX
|
IL |
|
A
|
AP Thailand PCL
SET:AP
|
TH |
|
Priority Technology Holdings Inc
NASDAQ:PRTH
|
US |
|
CPI Card Group Inc
F:CPB1
|
US |
|
Merdeka Copper Gold Tbk PT
F:B0C
|
ID |
|
K
|
Knowmerce Corp
KOSDAQ:473980
|
KR |
|
M
|
MC Mining Ltd
XMUN:G1V
|
AU |
|
S
|
Singapore Airlines Ltd
XMUN:SIA1
|
SG |
|
System1 Group PLC
LSE:SYS1
|
UK |
|
Keppel REIT
F:H27
|
SG |
|
Nedbank Group Ltd
F:NCO
|
ZA |
|
Coloplast A/S
CSE:COLO B
|
DK |
|
Watts Water Technologies Inc
NYSE:WTS
|
US |
|
T
|
Toho Holdings Co Ltd
F:TON
|
JP |
|
B
|
Berjaya Philippines Inc
XPHS:BCOR
|
PH |
|
B
|
Brazilian Electric Power Co
SWB:L3X
|
BR |
|
Cyfrowy Polsat SA
F:CP9
|
PL |
Amdocs Ltd (DOX)’s 12-month stock price forecast through October 2027 has a consensus target of $74.92, implying 21% upside. The forecast is based on price targets from 6 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
DOX is 74.92 USD with a low forecast of 63.63 USD and a high forecast of 110.25 USD.
Over the last 13 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 7 years is 4%.
Over the last 13 years, the compound annual growth rate for Gross Profit has been 3%. The projected CAGR for the next 5 years is 5%.
Over the last 13 years, the compound annual growth rate for Operating Income has been 5%. The projected CAGR for the next 3 years is 10%.
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 4%. The projected CAGR for the next 3 years is 16%.
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 5 years is 14%.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more